{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:19:15Z","timestamp":1755598755906},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.nrl.2015.12.002","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T18:30:17Z","timestamp":1455129017000},"page":"546-547","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis t\u00f3xica tras tratamiento concomitante con interfer\u00f3n beta y aloe vera en un paciente con esclerosis m\u00faltiple: a prop\u00f3sito de un caso"],"prefix":"10.1016","volume":"32","author":[{"given":"J.V.","family":"Herv\u00e1s-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Montan\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Serrado-Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ramo-Tello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2015.12.002_bib0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00002018-200326110-00006","article-title":"Hepatic reactions during treatment of multiple sclerosis with interferon-1\u03b1, incidence and clinical significance","volume":"26","author":"Francis","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.nrl.2015.12.002_bib0055","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00415-004-0619-5","article-title":"Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis","volume":"251","author":"Tremlett","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.nrl.2015.12.002_bib0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4166\/kjg.2014.64.1.54","article-title":"Acute toxic hepatitis caused by an aloe vera preparation in a young patient: A case report with a literature review","volume":"64","author":"Lee","year":"2014","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.nrl.2015.12.002_bib0065","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1345\/aph.1K132","article-title":"Oral aloe vera-induced hepatitis","volume":"41","author":"Bottenberg","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nrl.2015.12.002_bib0070","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.nrl.2015.12.002_bib0075","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s10620-012-2553-1","article-title":"Presentation and outcomes with clinically apparent interferon beta hepatotoxicity","volume":"58","author":"Fontana","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.nrl.2015.12.002_bib0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000354042","article-title":"Delayed liver function impairment secondary to interferon-1a use in multiple sclerosis","volume":"5","author":"Liao","year":"2013","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.nrl.2015.12.002_bib0085","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/01.wnl.0000219764.27182.c7","article-title":"Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy","volume":"66","author":"Pulicken","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2015.12.002_bib0090","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1111\/j.1468-1331.2011.03373.x","article-title":"Symptomatic liver injury (hepatotoxicity) associated with administration of complementary and alternative products (Ayurveda-AP-Mag Capsules\u00ae) in a beta-interferon-treated multiple sclerosis patient","volume":"18","author":"Tremlett","year":"2011","journal-title":"Eur J Neurol"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T10:23:22Z","timestamp":1537007002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485316000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0213485316000037"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2015.12.002","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis t\u00f3xica tras tratamiento concomitante con interfer\u00f3n beta y aloe vera en un paciente con esclerosis m\u00faltiple: a prop\u00f3sito de un caso","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}